Statherin levels in saliva of patients with precancerous and cancerous lesions of the oral cavity: A preliminary report

Oral Diseases

Volumn 11, Issue 2, 2005, Pages 95-99

  Contucci, Alessia Maria ^a   Inzitari, R ^a   Agostino, S ^a   Vitali, A ^a   Fiorita, A ^a   Cabras, T ^b   Scarano, E ^a   Messana, I ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Oral diseases; Saliva; Statherin

Indexed keywords

STATHERIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFLAMMATION; MALE; MOUTH CANCER; MOUTH CAVITY; PATHOLOGY; PRECANCER; PRIORITY JOURNAL; PROTEIN FUNCTION; SALIVA LEVEL; SALIVARY GLAND; SALIVARY GLAND DISEASE; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; LEUKOPLAKIA, ORAL; MALE; MIDDLE AGED; MOUTH NEOPLASMS; SALIVA; SALIVARY GLAND CALCULI; SALIVARY GLAND NEOPLASMS; SALIVARY PROTEINS; SIALADENITIS;

EID: 15944395779     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2004.01057.x     Document Type: Article

References (30)

1. Abiko Y, Mitamura J, Nishimura M et al (1999). Pattern of expression of beta-defensins in oral squamous cell carcinoma. Cancer Lett 143:37-43.
2. Amerongen NAV, Veerman ECI (2002). Saliva-the defender of oral cavity. Oral Dis 8:12-22.
3. + channel modulators on human prostate cancer cell proliferation. Eur J Pharmacol 471:157-164.
4. Castagnola M, Cabras T, Denotti G et al (2002). Circadian rhythms of Histatin 1, Histatin 3, Histatin 5, Statherin and Uric acid in whole human saliva secretion. Biol Rhythm Res 33:213-222.
5. Dayan D, Hirshberg A, Kaplan I et al (1997). Experimental tongue cancer in desalivated rats. Oral Oncol 33:105-109.
6. Edgar WM (1990). Saliva and dental health. Clinical implications of saliva: report and consensus meeting. Br Dent J 169:96-98.
7. Edgar WM (1992). Saliva: its secretion, composition and functions. Br Dent J 172:305-312.
8. Hawkins BL, Heniford BW, Ackermann DM et al (1994). 4NQO: a mouse model of oral cavity squamous cell carcinoma. Head Neck 16:424-432.
9. Humphrey SP and Williamson RT (2001). A review of saliva: normal composition, flow and function. J Prost Dent 85:162-168.
10. + channels inhibit human pancreatic cancer cell growth in vitro. Mol Pharmacol 65:630-8.
11. Johansson I, Bratt P, Hay DI et al (2000). Adhesion of Candida Albicans, built not Candida krusei, to salivary statherin and mimicking host molecules. Oral Microbiol Immunol 15:112-118.
12. Kaplan I, Engelberg J, Dayan D (2001). The effect of desalivation on 4-nitroquinoline-1-oxide-induced tongue carcinogenesis: a morphometric study of nucleolar organizer regions. J Oral Pathol Med 30:48-52.
13. Kaplan I, Hochstadt T, Dayan D (2002). PCNA in palate and tongue mucosal dysplastic lesions induced by topically applied 4NQO in desalivated rats. Med Oral 7:336-343.
14. Kondakova I, Lissi EA, Pizarro M (1999). Total reactive antioxidant potential in human saliva of smokers and non-smokers. Biochem Mol Biol Int 47:911-920.
15. Lamkin MS and Oppenheim FG (1993). Structural features of salivary function. Critical Rev Oral Biol Med 4:251-259.
16. Lekholm U, Wallenius K (1976). Experimental oral cancer in rats with xerostomia. Odontol Rev 27:11-18.
17. Lekholm V, Wallenius K, Heyden G (1975). Alterations in the lipidic content of rat palatal epitelium during carcinogenesis. Histochemistry 44:147-154.
18. Maier H, Born IA, Adler D (1986). Limited function of the large salivary glands of the head. A new aspect for the pathogenesis of cancers of the oral cavity, oropharynx and hypopharynx. Laryngol Rhinol Otol 65:195-200.
19. Mizukawa N, Sugiyama K, Fukunaga J et al (1998). Defensin-1, a peptide detected in the saliva of oral squamous cell carcinoma patients. Anticancer Res 18:4645-4650.
20. Mizukawa N, Sugiyama K, Ueno T et al (1999). Defensin-1, an antimicrobical peptide present in saliva of patients with oral diseases. Oral Dis 5:139-142.
21. Mizukawa N, Sugiyama K, Kamio M et al (2000). Immunohistochemical staining of human alpha-defensin-1 (HNP-1), in the submandibular glands of patients with oral carcinomas. Anticancer Res 20:1125-1127.
22. Mizukawa N, Sugiyama K, Ueno T et al (2002). Levels of human defensin-1, an antimicrobial peptide, in saliva of patients with oral inflammation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 87:539-543.
23. Mooe S, Calder KAC, Miller NJ et al (1994). Antioxidant activity of saliva and periodontal disease. Free Radic Res 21:417-425.
24. Nagler RM, Klein I, Karzhevesky N et al (2002). Caharacterization of the differentiated antioxidant profile of human saliva. Free Radic Biol Med 32:268-277.
25. + channels in breast cancer cells: association with cell cycle progression. Am J Physiol Cell Physiol 287:125-34.
26. + channels. EMBO (Eur Mol Biol Organ) J 18:5540-5547
27. Raj PA, Jhonsson M, Levine MJ et al (1992). Dependence on sequence, charge, hydrogen bonding potency, and helical conformation for adsorption to hydroxyapatiteand inhibition of mineralization. J Biol Chem 267:5968-5976.
28. Rao RK, Thomas DW, Pepperl S et al (1997). Salivary epidermal growth factor plays a role in the protection of ileal mucosal integrity. Dig Dis Sci 42:2175-2181.
29. + channels in the proliferation of pancreatic carcinoma cells. Biophys J 80:101a.
30. Sawaki K, Mizukawa N, Yamaai T et al (2002). High concentration of beta-defensin-2 in oral squamous cell carcinoma. Anticancer Res 22:2103-2107.